News
-
Last ditch OTC codeine cry
Wednesday | Jan 10 2018AN ELEVENTH-HOUR plea from the Extended Hours Pharmacies Association (EHPA) has urged NSW parliamentarians to support a change to allow low-dosage codeine to continue to be available over-the-counter after 01 Feb 2018.
-
Guild Update 09 Jan 18: Member briefings 2018
Tuesday | Jan 9 2018FOLLOWING the series of successful Member briefings conducted in 2017, the Guild will again conduct briefings.
-
Dispensary Corner 09 Jan 18
Tuesday | Jan 9 2018VIAGRA gets the blame again - this time from a naked faeces-flinging 27-year-old South Korean man in Thailand's Phuket International Airport.
-
Vale Geoffrey Vaughan AO
Tuesday | Jan 9 2018THE Australian pharmacy sector is this week mourning the death of Dr Geoffrey Vaughan AO, who was Dean of the Victorian College of Pharmacy from 1979 to 1986.
-
MedsASSIST to shut down
Tuesday | Jan 9 2018THE Pharmacy Guild of Australia has announced that its MedsASSIST real time recording system, developed to help reduce the misuse of over-the-counter combination analgesic medicines containing codeine, will be discontinued after 31 Jan 2018.
-
Weekly Comment 08 Jan 18: The importance of the three-step process
Monday | Jan 8 2018WELCOME to PD's weekly comment feature.
-
Dispensary Corner 08 Jan 18
Monday | Jan 8 2018EVERYONE would like to win the lottery, and in South Carolina, USA, courtesy of a festive season technical glitch, everyone who entered, did.
-
Integrate primary care – CHF
Monday | Jan 8 2018THE Consumers Health Forum (CHF) has called upon the Federal Government to fund integrated primary care, delivered in the community and providing services that avoid the need for more costly hospitalisation, among a series of measures presented in the group's 2018 federal budget submission.
-
Walgreens sales up
Monday | Jan 8 2018AMERICAN pharmacy giant Walgreens has reported a strong quarter, with its retail division posting sales of US$22.5 billion for the three months to 31 Dec - up 9%.
-
Pfizer drops neuro drug research
Monday | Jan 8 2018PFIZER has announced the cessation of R&D programs focused on early stage drugs for neuroscience, including Alzheimer's and Parkinson's disease.
